Journal of Postgraduate Medicine
 Open access journal indexed with Index Medicus & ISI's SCI  
Users online: 7122  
Home | Subscribe | Feedback | Login 
About Latest Articles Back-Issues Articlesmenu-bullet Search Instructions Online Submission Subscribe Etcetera Contact
 
  NAVIGATE here  
  ::   Search
  ::   Ahead of print
  ::   Current Issue
  ::   Submit Article 
  ::   Apply as Referee 
  ::   JPGM WriteCon 
  ::   Current Symposium 

 


This article has been cited by
1Expression of Somatostatin Receptor 2 in Somatotropinoma Correlated with the Short-Term Efficacy of Somatostatin Analogues
Wenjuan Liu,Lina Xie,Min He,Ming Shen,Jingjing Zhu,Yeping Yang,Meng Wang,Ji Hu,Hongying Ye,Yiming Li,Yao Zhao,Zhaoyun Zhang
International Journal of Endocrinology.2017;2017()1
[DOI]
2The value of an acute octreotide suppression test in predicting short-term efficacy of somatostatin analogues in acromegaly
Meng Wang,Ming Shen,Wenqiang He,Yeping Yang,Wenjuan Liu,Yun Lu,Zengyi Ma,Zhao Ye,Yichao Zhang,Xiaolong Zhao,Bin Lu,Ji Hu,Yun Huang,Xuefei Shou,Yongfei Wang,Hongying Ye,Yiming Li,Shiqi Li,Yao Zhao,Zhaoyun Zhang
Endocrine Journal.2016;63(9)819
[DOI]
3Cytoplasmic expression of SSTR2 and 5 by immunohistochemistry and by RT/PCR is not associated with the pharmacological response to octreotide
Baldomero Gonzalez,Guadalupe Vargas,Claudia Ramirez,Silvia Asa,Sonia Cheng,Carolina Sandoval,Moises Mercado
Endocrinología y Nutrición.2014;61(10)523
[DOI]
4The characteristics of acromegalic patients with hyperprolactinemia and the differences in patients with merely GH-secreting adenomas: clinical analysis of 279 cases
M. Wang,C. Mou,M. Jiang,L. Han,S. Fan,C. Huan,X. Qu,T. Han,Y. Qu,G. Xu
European Journal of Endocrinology.2012;166(5)797
[DOI]
5Real-world comorbidities and treatment patterns of patients with acromegaly in two large US health plan databases
Tanya Burton,Elisabeth Le Nestour,Tim Bancroft,Maureen Neary
Pituitary.2013;16(3)354
[DOI]
6Cytoplasmic expression of SSTR2 and 5 by immunohistochemistry and by RT/PCR is not associated with the pharmacological response to octreotide
Baldomero Gonzalez,Guadalupe Vargas,Claudia Ramirez,Silvia Asa,Sonia Cheng,Carolina Sandoval,Moises Mercado
Endocrinología y Nutrición (English Edition).2014;61(10)523
[DOI]
7Treatment of acromegaly in the era of personalized and predictive medicine
Manuel Puig Domingo
Clinical Endocrinology.2015;83(1)3
[DOI]
8Diagnosis, treatment and clinical perspectives of acromegaly
Ferdinand Roelfsema,Gerrit van den Berg
Expert Review of Endocrinology & Metabolism.2015;10(6)619
[DOI]
9Interpreting biochemical control response rates with first-generation somatostatin analogues in acromegaly
Annamaria Colao,Renata S. Auriemma,Rosario Pivonello,Leandro Kasuki,Mônica R. Gadelha
Pituitary.2016;19(3)235
[DOI]
10Magnetic resonance spectroscopy may serve as a presurgical predictor of somatostatin analog therapy response in patients with growth hormone-secreting pituitary macroadenomas
J. Hu,J. Yan,X. Zheng,Y. Zhang,Q. Ran,X. Tang,T. Shu,R. Shen,L. Duan,D. Zhang,Q. Guo,W. Zhang,H. Yang,S. Li
Journal of Endocrinological Investigation.2019;42(4)443
[DOI]
Online since 12th February '04
© 2004 - Journal of Postgraduate Medicine
Official Publication of the Staff Society of the Seth GS Medical College and KEM Hospital, Mumbai, India
Published by Wolters Kluwer - Medknow